Société Générale — M&A Activity 2021

Jun 18, 2021

National Storage Mechanism | Additional information

RNS Number : 3645C

Societe Generale SA

18 June 2021

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1)	Société Générale S.A.
Company dealt in	UDG Healthcare plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	€0.05 ordinary shares
Date of dealing	17/06/2021

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
Number	(%)	Number	(%)
(1) Relevant securities	10,276,725	4.08	9,404	0.00
(2) Derivatives (other than options)	0	0.00	6,233,855	2.47
(3) Options and agreements to purchase/sell	0	0.00	0	0.00
Total	*10,336,725	*4.10	6,243,259	2.48

* Include the holding of 60,000 shares on borrow products

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit GBP (Note 5)
Purchase	2	10.59
Purchase	191	10.49
Purchase	269	10.49
Purchase	1,052	10.52
Purchase	45	10.59
Purchase	422	10.5
Purchase	8,726	10.5
Purchase	2	10.55
Purchase	1	10.52
Purchase	37	10.52
Purchase	1	10.52
Purchase	2	10.59
Purchase	96	10.48
Purchase	97	10.48
Purchase	97	10.48
Purchase	34	10.48
Purchase	96	10.48
Sale	249	10.47
Sale	332	10.54
Sale	2	10.59
Sale	244	10.58
Sale	392	10.48
Sale	191	10.53
Sale	196	10.51
Sale	398	10.54
Sale	130	10.57
Sale	128	10.57
Sale	2	10.59
Sale	107	10.48
Sale	336	10.46
Sale	269	10.46
Sale	895	10.52
Sale	346	10.52
Sale	259	10.54
Sale	1,212	10.53
Sale	2,631	10.48
Sale	207	10.47
Sale	871	10.52
Sale	904	10.53
Sale	939	10.55
Sale	937	10.54
Sale	490	10.54
Sale	852	10.57
Sale	873	10.56
Sale	863	10.58
Sale	45	10.59
Sale	265	10.48
Sale	250	10.47
Sale	542	10.55
Sale	400	10.59
Sale	228	10.48
Sale	212	10.59
Sale	328	10.59
Sale	2,730	10.59
Sale	290	10.48
Sale	250	10.48
Sale	927	10.48
Sale	1,899	10.52
Sale	400	10.52
Sale	240	10.52
Sale	385	10.52
Sale	250	10.52
Sale	4,173	10.48
Sale	478	10.52
Sale	249	10.52
Sale	2,660	10.53
Sale	1,496	10.48
Sale	354	10.54
Sale	97	10.48
Sale	97	10.48
Sale	34	10.48
Sale	96	10.48
Sale	96	10.48
Total Purchases	11,170
Total Sales	34,726

Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit GBP (Note 5)

(b)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(c)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements, or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the 

voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition 

or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure	18/06/2021
Contact name	Société Générale - Disclosure team
Telephone number	+33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEEAKKPFEXFEEA